BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25544963)

  • 21. The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults.
    Lugowska I; Mierzejewska E; Lenarcik M; Klepacka T; Koch I; Michalak E; Szamotulska K
    Tumour Biol; 2016 Sep; 37(9):12071-12078. PubMed ID: 27207343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma.
    Wu J; Guo A; Li Q; Wang D
    Future Oncol; 2017 Sep; 13(21):1883-1891. PubMed ID: 28766969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of CD44 expression in osteosarcoma: evidence from six studies.
    Liu Y; Wu Y; Gu S; Sun Z; Rui Y; Wang J; Lu Y; Li H; Xu K; Sheng P
    Diagn Pathol; 2014 Aug; 9():140. PubMed ID: 25112408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of ezrin in osteosarcoma metastasis.
    Ren L; Khanna C
    Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.
    Zhang W; Ren X; Qi L; Zhang C; Tu C; Li Z
    BMC Cancer; 2021 Feb; 21(1):202. PubMed ID: 33639865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells.
    Zhao H; Guo M; Zhao G; Ma Q; Ma B; Qiu X; Fan Q
    Int J Mol Med; 2012 Nov; 30(5):1013-20. PubMed ID: 22922800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between PTEN and clinical-pathological features of osteosarcoma.
    Zhou J; Xiao X; Wang W; Luo Y
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31270249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ezrin, a key component in tumor metastasis.
    Hunter KW
    Trends Mol Med; 2004 May; 10(5):201-4. PubMed ID: 15121044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
    Liu P; Yang P; Zhang Z; Liu M; Hu S
    Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ezrin and moesin expression in canine and feline osteosarcoma.
    Hlavaty J; Wolfesberger B; Hauck M; Obermayer-Pietsch B; Fuchs-Baumgartinger A; Miller I; Walter I
    Histol Histopathol; 2017 Aug; 32(8):805-816. PubMed ID: 27900754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma.
    Li Z; Liao Q; Wu Y; Liao M; Hao Y; Zhang S; Song S; Li B; Zhang YD
    Pathol Oncol Res; 2012 Jul; 18(3):657-61. PubMed ID: 22215309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice.
    Jaroensong T; Endo Y; Lee SJ; Kamida A; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
    Vet Comp Oncol; 2012 Dec; 10(4):274-82. PubMed ID: 22236104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of ezrin and metastatic tumor antigen in osteosarcomas of the jaw.
    Park HR; Cabrini RL; Araujo ES; Paparella ML; Brandizzi D; Park YK
    Tumori; 2009; 95(1):81-6. PubMed ID: 19366061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of novel gene URG4 in osteosarcoma: correlation with patients' prognosis.
    Huang J; Zhu B; Lu L; Lian Z; Wang Y; Yang X; Satiroglu-Tufan NL; Liu J; Luo Z
    Pathology; 2009 Feb; 41(2):149-54. PubMed ID: 18972316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ezrin promotes invasion and migration of the MG63 osteosarcoma cell.
    Zhang J; Zuo J; Lei M; Wu S; Zang X; Zhang C
    Chin Med J (Engl); 2014; 127(10):1954-9. PubMed ID: 24824262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
    Wang G; Shen N; Cheng L; Lin J; Li K
    Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma.
    Paige M; Kosturko G; Bulut G; Miessau M; Rahim S; Toretsky JA; Brown ML; Üren A
    Bioorg Med Chem; 2014 Jan; 22(1):478-87. PubMed ID: 24326277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High level of ezrin mRNA expression in an osteosarcoma biopsy sample with lung metastasis.
    Ogino W; Takeshima Y; Mori T; Yanai T; Hayakawa A; Akisue T; Kurosaka M; Matsuo M
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):435-9. PubMed ID: 17609619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors.
    Machado I; Navarro S; Giner F; Alberghini M; Bertoni F; Llombart-Bosch A
    Virchows Arch; 2010 Jul; 457(1):87-9. PubMed ID: 20552365
    [No Abstract]   [Full Text] [Related]  

  • 40. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
    Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.